肾和输尿管移行细胞癌中的腹膜后淋巴结
Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.
作者信息
Kundu Shilajit D, Eggener Scott E
机构信息
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
出版信息
Adv Urol. 2009;2009:181927. doi: 10.1155/2009/181927. Epub 2009 Jan 26.
Abstract
The incidence of transitional cell carcinoma of the kidney and ureter is low and for that reason limited data exists regarding the appropriate management of regional retroperitoneal lymph nodes. Lymph node metastases have consistently been associated with an adverse prognosis. However, five-year cancer-specific survival following nephroureterectomy and lymphadenectomy for patients with lymph node involvement ranges from 0-39%, suggesting a therapeutic benefit. This review covers the primary tumor characteristics associated with lymph node involvement, imaging of the lymph nodes, as well as the rationale, role, patient selection, suggested anatomic templates, and technical considerations for lymphadenectomy.
摘要
肾和输尿管移行细胞癌的发病率较低，因此关于区域腹膜后淋巴结的适当管理的数据有限。淋巴结转移一直与不良预后相关。然而，对于有淋巴结受累的患者，肾输尿管切除术和淋巴结清扫术后的五年癌症特异性生存率为0%-39%，提示有治疗益处。本综述涵盖了与淋巴结受累相关的原发性肿瘤特征、淋巴结的影像学检查，以及淋巴结清扫术的基本原理、作用、患者选择、建议的解剖模板和技术要点。
相似文献
1
Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.
Adv Urol. 2009;2009:181927. doi: 10.1155/2009/181927. Epub 2009 Jan 26.
2
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
J Urol. 2015 Dec;194(6):1567-74. doi: 10.1016/j.juro.2015.06.077. Epub 2015 Jun 19.
3
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
Urol Oncol. 2016 Dec;34(12):531.e15-531.e24. doi: 10.1016/j.urolonc.2016.06.013. Epub 2016 Jul 27.
4
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
World J Urol. 2017 Apr;35(4):535-548. doi: 10.1007/s00345-016-1764-z. Epub 2016 Jan 25.
5
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
J Urol. 2003 Jun;169(6):2113-7. doi: 10.1097/01.ju.0000067601.29966.4a.
6
Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.
Int J Clin Oncol. 2017 Feb;22(1):145-152. doi: 10.1007/s10147-016-1024-7. Epub 2016 Jul 23.
7
Lymphadenectomy in bladder cancer: how high is "high enough"?
Urol Oncol. 2006 Jul-Aug;24(4):349-55. doi: 10.1016/j.urolonc.2005.07.013.
8
Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
Urology. 2007 Feb;69(2):265-9. doi: 10.1016/j.urology.2006.10.014.
9
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
J Urol. 2003 Jul;170(1):35-41. doi: 10.1097/01.ju.0000072422.69286.0e.
10
Standardized and Simplified Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Ureter or Renal Pelvis: En Bloc Resection Technique.
Urology. 2018 Feb;112:85-91. doi: 10.1016/j.urology.2017.11.001. Epub 2017 Nov 20.
引用本文的文献
1
Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy.
Indian J Urol. 2018 Jan-Mar;34(1):68-73. doi: 10.4103/iju.IJU_216_17.
2
Investigating the flow dynamics in the obstructed and stented ureter by means of a biomimetic artificial model.
PLoS One. 2014 Feb 3;9(2):e87433. doi: 10.1371/journal.pone.0087433. eCollection 2014.
本文引用的文献
1
Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic.
Urology. 2008 Mar;71(3):413-6. doi: 10.1016/j.urology.2007.10.028.
2
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
J Urol. 2008 Mar;179(3):873-8; discussion 878. doi: 10.1016/j.juro.2007.10.076. Epub 2008 Jan 25.
3
Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
Eur Urol. 2008 Apr;53(4):794-802. doi: 10.1016/j.eururo.2008.01.008. Epub 2008 Jan 15.
4
The Will Rogers phenomenon in urological oncology.
J Urol. 2008 Jan;179(1):28-33. doi: 10.1016/j.juro.2007.08.125. Epub 2007 Nov 13.
5
Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
J Urol. 2007 Dec;178(6):2291-6; discussion 2296. doi: 10.1016/j.juro.2007.08.019. Epub 2007 Oct 22.
6
Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Cancer. 2007 Oct 15;110(8):1715-22. doi: 10.1002/cncr.22970.
7
Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
J Urol. 2007 Oct;178(4 Pt 1):1212-7; discussion 1217. doi: 10.1016/j.juro.2007.05.158. Epub 2007 Aug 14.
8
Management of patients with upper urinary tract transitional cell carcinoma.
Nat Clin Pract Urol. 2007 Aug;4(8):432-43. doi: 10.1038/ncpuro0875.
9
Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Eur Urol. 2007 Nov;52(5):1414-8. doi: 10.1016/j.eururo.2007.04.070. Epub 2007 May 2.
10
Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
Urology. 2007 Feb;69(2):265-9. doi: 10.1016/j.urology.2006.10.014.
Zotero 插件